Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...

A new drug could dramatically ease the pain and misery of the 60,000 people in the UK who suffer from rheumatoid arthritis. Specialists believe that the drug, Remicade, is a major breakthrough in ...

The changes in drug therapy from 2003 to 2010 ... Recent changes in both treatments and outcomes of rheumatoid arthritis (RA) in Japan were analyzed by viewing the 'National Database of Rheumatic ...

Rheumatoid arthritis brings relentless pain and fatigue. Learn about one person's experiences with treatments, joint replacements, and surgeries.

CRP: C-reactive protein; DMARD: Disease-modifying antirheumatic drug; ESR ... Recent changes in both treatments and outcomes of rheumatoid arthritis (RA) in Japan were analyzed by viewing the ...

The new treatment targets inflammation directly within the joints so that therapeutic agents are released only when needed.

Researchers from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institution of the Department of Science and Technology (DST), have developed an innovative “self-actuating” ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...